A critical role for DnaJ heat shock protein family (Hsp40) member C12 (DNAJC12) in breast cancer chemotherapy resistance was identified, as DNAJC12 was shown to suppress both DOX-induced ferroptosis and apoptosis, contributing to treatment resistance. This evidence concerns the gene DNAJC12 and breast carcinoma.